Marcus Lemonis - 04 Feb 2026 Form 4 Insider Report for BED BATH & BEYOND, INC. (BBBY)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
06 Feb 2026, 16:09:17 UTC
Prior SEC filing
16 Dec 2025
Next SEC filing
12 Mar 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Christina Wheeler, Attorney-in-Fact

Key filing fact

Marcus Lemonis filed Form 4 for BED BATH & BEYOND, INC. (BBBY) on 06 Feb 2026.

Key facts

  • This page summarizes Marcus Lemonis's Form 4 filing for BED BATH & BEYOND, INC. (BBBY).
  • 2 reported transactions and 2 derivative rows are listed below.
  • Accepted by SEC: 06 Feb 2026, 16:09.

Change

  • Previous filing in this sequence was filed on 16 Dec 2025.
  • Current net transaction value: +$470.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001136478 Primary reporting owner

LEMONIS MARCUS

Relationship
EXECUTIVE CHAIRMAN & CEO, Director
Address
433 ASCENSION WAY, 3RD FLOOR, MURRAY
Signature
/s/ Christina Wheeler, Attorney-in-Fact
Signature date
06 Feb 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

BBBY transaction Derivative

Performance Shares

Award

Transaction value
$424
Shares
+424,300
Change %
Price
$0.001000
Shares after
424,300
Date
04 Feb 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
424,300
Exercise price
Footnotes
F1
BBBY transaction Derivative

Common Stock Warrants

Award

Transaction value
$45.62
Shares
+45,615
Change %
+4561500%
Price
$0.001000
Shares after
45,616
Date
07 Oct 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
45,615
Exercise price
$15.50
Footnotes
F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Each performance share represents a contingent right to receive one share of Bed Bath & Beyond, Inc. common stock. On March 10, 2025 the reporting person was granted an award of performance shares, which are scheduled to vest in three equal installments at the close of business on March 10, 2026, March 10, 2027, and March 10, 2028, subject to and upon the satisfaction of certain performance criteria. On February 4, 2026, the compensation committee of the Issuer's board of directors determined that a total of 424,300 performance shares were earned based on performance relative to the performance criteria for fiscal year 2025. Accordingly, the earned performance shares will vest based on continued service through the applicable vesting date specified above.

Footnote F2

Represents warrants that were originally issued on October 7, 2025 as a pro-rata distribution to all holders of common stock. Each warrant entitles the holder to purchase one share of the Registrant's common stock at an exercise price of $15.50 per warrant. This distribution was exempt from immediate reporting under Section 16.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .